Canes and Crutches Market

How big is the Canes and Crutches Market in 2026?

Revenue in the global canes and crutches market is forecast to rise to USD 1,541.7 million by 2036 at a CAGR of 4.5% between 2026 and 2036. The market was valued at USD 950.0 million in 2025, with USD 992.8 million estimated for 2026.

Canes and Crutches Market Size and Forecast

Table 1: Canes and Crutches Market Size and Forecast

Market size and forecast	Value
Market size in 2025	USD 950.0 million
Estimated market size in 2026	USD 992.8 million
Projected market size by 2036	USD 1,541.7 million
CAGR from 2026 to 2036	4.5%

Source: Future Market Insights analysis of the canes and crutches market, 2026.

Retail access and public purchasing rules create different sources of demand. A standard cane sold directly to a household follows a different sales process from a reimbursed forearm crutch. Ontario explicitly includes forearm crutches in its Assistive Devices Program while excluding standard walking canes. In the United States, Medicare coverage depends on an eligible functional limitation and safe use. A written order is required before a claim is submitted. These distinctions give pharmacies and medical suppliers a continuing role even as online sales increase.

Availability also depends on a supplier's breadth. Medline unveiled a second automated storage installation at its Rialto distribution centre in May 2025. The investment served its wider medical distribution business, so a broad distributor competes differently from a specialist walking-stick manufacturer. In January 2026, Drive Medical announced an agreement to acquire Compass Health Brands. Its German business subsequently described acquisition and integration of the company, although neither source gives a completion date. FMI expects these changes to influence dealer assortment and purchasing relationships.

Key Market Trends & Insights

• Distribution changes faster than product leadership. Online revenue share rises to 32.5% in 2036 from 24.0% in 2026, overtaking retail pharmacies at 31.9% by the end of the forecast.
• Material upgrading occurs within a market still dominated by aluminium. Carbon and composite products increase from 18.0% to 22.3% of revenue between 2026 and 2036. Ossenberg's catalogue documents carbon forearm crutches alongside its conventional walking-aid ranges.
• Institutional reuse limits the relationship between patient activity and new-device sales. A February 2026 service at Leighton Hospital accepts elbow crutches and walking sticks for assessment, cleaning and refurbishment.

Regional Highlights

• The weight of China and India in global revenue increases. Projected 2036 shares are China 7.2% (from 6.0%) and India 3.8% (from 3.0%).
• Global share declines for Germany, Japan and the United Kingdom even as revenue grows. FMI projects Germany slipping from 8.0% to 7.6%, Japan slipping from 7.0% to 6.6% and the United Kingdom slipping from 6.0% to 5.7% over 2026 to 2036.

Analyst Perspective

“Distribution will change more sharply than the basic product mix. Online sellers are projected to overtake pharmacies by revenue share in 2036, but funded supply still depends on the rules for a particular device and patient. Suppliers should distinguish their ordinary retail offer from their reimbursed or institutional range. Carbon products have room to increase value, provided their weight, grip and adjustment advantages are documented for the intended user. A premium material description alone is a weak basis for switching an established rehabilitation purchase.”

- Anurag Sharma, Principal Consultant, FMI

How is the Canes and Crutches Market segmented?

• By product: Canes, Forearm crutches, and Underarm crutches.
• By material: Aluminium, Wood, and Carbon and composite.
• By distribution: Retail pharmacies, Online, Hospitals and clinics, and Medical supply stores.
• By region: North America, Europe, East Asia, South Asia and Pacific, and Rest of world.

Why does the Canes segment lead by Product in the Canes and Crutches Market in 2026?

The Canes segment holds 52.0% of the Canes and Crutches Market by product in 2026.

The cane business covers a wider retail assortment than a single clinical specification. Drive's direct catalogue separates folding, offset, quad and T-handle canes. That variety creates different stocking decisions from those for an underarm crutch supplied in standard size bands. A retailer can carry a compact folding option and a larger-base support as separate stock lines.

FMI forecasts cane revenue of USD 516.2 million in 2026 and USD 772.8 million in 2036. Forearm crutches grow faster at 5.1% CAGR, compared with 4.1% for canes. The cane share eases from 52.0% to 50.1% and the segment keeps its lead. Forearm-crutch revenue reaches USD 441.5 million in 2036, with underarm crutches at USD 327.4 million.

Product selection remains bounded by the assessment of an individual's mobility. Suppliers seeking higher value in canes need a clear assortment strategy around grip, base and portability. They also need to identify when the appropriate sale belongs in another product category.

Forearm crutches and Underarm crutches together hold the remaining 48.0% by product.

Table 2: Product, 2026 Share

Leading Share	2026 market share
Canes	52.0%
All Other Segments Combined Share	48.0%

Source: Future Market Insights analysis of the canes and crutches market, 2026.

Why does the Aluminium segment lead by Material in the Canes and Crutches Market in 2026?

The Aluminium segment holds 68.0% of the Canes and Crutches Market by material in 2026.

Aluminium spans ordinary canes and crutches, giving it exposure to both household purchases and institutional orders. Medline lists aluminium forearm crutches and an aluminium quad cane in its consumer range. The two products share a material and differ in specification. A common material lets a supplier assemble a broad mobility assortment across price points.

FMI estimates aluminium revenue at USD 675.1 million in 2026 and USD 1,024.4 million in 2036. Its share eases to 66.4% as carbon and composite products reach USD 343.5 million. Wood grows more slowly, with revenue increasing from USD 139.0 million to USD 173.8 million. The forecast therefore combines a large conventional-material base with a smaller upgrading opportunity.

Premium materials support a differentiated range for a specialist supplier. The relevant comparison concerns the complete device and its documented limits. Purchasers need to compare the weight of equivalent products, the available sizes and the replacement components. FMI expects premium material suppliers to gain selectively where those differences are material to a continuing user's choice.

Wood and Carbon and composite together hold the remaining 32.0% by material.

Table 3: Material, 2026 Share

Leading Share	2026 market share
Aluminium	68.0%
All Other Segments Combined Share	32.0%

Source: Future Market Insights analysis of the canes and crutches market, 2026.

Why does the Retail pharmacies segment lead by Distribution in the Canes and Crutches Market in 2026?

The Retail pharmacies segment holds 36.0% of the Canes and Crutches Market by distribution in 2026.

The pharmacy lead sits within a divided market. Retail pharmacies generate USD 357.4 million in 2026, followed by online sales at USD 238.3 million. Hospitals and clinics account for USD 218.4 million, with medical supply stores at USD 178.7 million. These channels differ in the transaction they manage. A retail purchase can be immediate, while an institutional issue may form part of a planned discharge or rehabilitation service.

Consumer-facing manufacturer sites already sell canes and crutches directly, with distinct product categories and access to replacement accessories. FMI forecasts online revenue growth at 7.7% CAGR to USD 501.3 million in 2036. Pharmacy revenue reaches USD 491.3 million at 3.2% CAGR.

Local retail retains a role in checking the physical product before purchase. A routine replacement can move to another channel. A returning buyer who knows the model has a different transaction from a first-time customer selecting a new aid. Clear product identifiers and selling quantities become valuable online. The broader homecare medical devices market provides context for this separation between household retail and clinically organised supply.

Online, Hospitals and clinics and Medical supply stores together hold the remaining 64.0% by distribution.

Table 4: Distribution, 2026 Share

Leading Share	2026 market share
Retail pharmacies	36.0%
All Other Segments Combined Share	64.0%

Source: Future Market Insights analysis of the canes and crutches market, 2026.

What are the key drivers restraints and opportunities?

Demand grows through a combination of rehabilitation access, replacement purchases and wider retail distribution. Public funding conditions and reuse constrain new-device sales. Specialist materials and clearer online assortments offer additional value.

Driver

Organised access to walking supports brings eligible users into funded and retail purchasing channels.

Restraint

Reissued equipment and tightly defined reimbursement can reduce the number of new devices bought for a given level of patient need.

Opportunity

Suppliers can develop distinct conventional and specialist ranges while making model selection and replacement purchasing clearer online.

How do purchasing rules and qualification affect canes and crutches market demand?

Sales depend on access as well as need. WHO identifies cost, procurement and workforce limitations among the barriers to assistive technology access. For canes and crutches, the commercial issue is whether a person reaches a channel that can supply the appropriate product. Public provision, a pharmacy purchase and a direct online order may each produce a device sale, but the payment and selection process differs.

This is why distribution deserves as much attention as the overall growth rate. India and China have the fastest country CAGRs in this outlook, while the United States remains the largest revenue market. The former markets offer expansion from a smaller revenue base. The latter supports established purchasing routes with more limited share movement. Suppliers should plan stock and local partnerships around those distinct commercial conditions. Walkers and rollators sold through the same retail routes are covered in FMI's walking aid market.

What limits reliable canes and crutches market supply and quality?

Institutional reuse lets one device serve several patients over time. The effect depends on the proportion returned, the products accepted and the cost of refurbishment. Manufacturers serving such buyers have a reason to consider replaceable wear parts and a stable product range.

Funding restrictions present a separate constraint. In Canada, the Ontario programme distinguishes eligible forearm crutches from ordinary canes. A low product price leaves the transaction barrier in place where assessment, travel or delivery is also required. FMI expects price-sensitive purchasing to remain important across conventional products, even while specialist materials raise the value of selected sales.

Where can suppliers win additional business in the canes and crutches market?

Online growth and carbon-material expansion are separate opportunities. One changes where the sale occurs, while the other changes what is sold. An aluminium replacement cane can be an effective online product when its specification is clear. A specialist carbon crutch may require more detailed selection and support.

The forecast points to room for both. Aluminium still accounts for 66.4% of 2036 revenue, while online reaches 32.5% of channel revenue. A supplier's advantage will depend on matching its range to the customer and payment route. The eldercare mobility device market is relevant to wider household mobility needs, although its additional products are excluded from this assessment.

Canes and Crutches Market by Country (2026 to 2036)

Table 5: Canes and Crutches Market Country Growth Forecast

Country	CAGR, 2026 to 2036
India	6.9%
China	6.4%
United States	4.4%
Canada	4.4%
Australia	4.4%
Germany	3.9%
Japan	3.9%
United Kingdom	3.9%
France	3.9%
Italy	3.9%

Source: Future Market Insights analysis of the canes and crutches market, 2026.

India

Public assisted-living distribution is a distinct source of Indian demand. The government's October 2025 senior-citizen briefing identifies walking sticks and elbow crutches within Rashtriya Vayoshri Yojana. The programme supplies eligible low-income older people with assisted-living devices through an organised provision route. This creates a different commercial setting from a household visiting a pharmacy after an injury.

India has the highest named-country growth rate in this assessment. FMI forecasts revenue of USD 29.8 million in 2026 and USD 58.2 million in 2036, with a 6.9% CAGR over 2026 to 2036. The country starts at the same rounded revenue value as Australia but generates a larger increase during the period. Its global revenue share reaches 3.8% in 2036. In the canes and crutches market, India adds USD 28.4 million, ranking fifth for increase.

The supplier opportunity involves affordable standard devices and dependable delivery through the relevant channel. Public provision and private retail can require different pack configurations and ordering arrangements. FMI expects distributors to benefit from keeping public provision and private retail offers separate. A broad mobility catalogue can support relationships with rehabilitation sellers, and adjacent wheelchair products sit outside cane revenue. The commercial priority is to convert access into an appropriate supplied product. Wider availability needs to be accompanied by a range that is understandable to the purchaser and suitable for the intended use.

China

The expansion of China's age-friendly product assortment creates a supply-side opportunity and a selection problem. In May 2025, the State Administration for Market Regulation reported 6,000 new walking-assistance product varieties during the first four months of the year. Its category included canes, wheelchairs and mobility scooters. The figure measures new varieties across that wider group.

Against that backdrop, FMI forecasts Chinese canes and crutches revenue of USD 59.6 million in 2026 and USD 111.1 million in 2036. The 6.4% CAGR over 2026 to 2036 sits above the global rate. China's revenue share rises from 6.0% to 7.2%. This makes the country important to incremental revenue even though its starting value is substantially below that of the United States. China records a USD 51.5 million increase, second of the ten. On 2026 revenue, China stands joint fourth in the ten-country set.

The commercial task for distributors is to make an expanding assortment usable. More product variants can increase choice while also making equivalent offers harder to compare. FMI sees an advantage in a concise range organised by product, material and intended user requirements. That is particularly relevant when the same seller offers both ordinary aluminium devices and specialist composites. The stronger growth outlook supports investment in comparable offers and reliable ordering. Distributors gain when a wider range remains straightforward to purchase.

United States

Reimbursed supply in the United States begins with a functional requirement and not with the customer's age. Medicare's Canes and Crutches policy covers specified products when a mobility limitation affects daily activities in the home. It also requires safe use and sufficient resolution of that deficit. A standard written order must reach the supplier before the claim is submitted. Those conditions make the documentation process commercially relevant to a supplier serving covered purchases.

FMI projects US revenue to rise from USD 297.8 million in 2026 to USD 459.8 million in 2036 at a 4.4% CAGR. The country represents 30.0% of global revenue in 2026. A reimbursed order has a different administrative burden from a direct replacement purchase. In the canes and crutches market, the United States grows 4.4% a year, 0.1 points below the global rate.

For manufacturers, a broad catalogue needs a clear separation between standard cane models and crutches with distinct sizes or weight limits. The US opportunity is therefore partly an assortment and fulfilment business. Suppliers can improve their offer by keeping the same model identifiers across ordering, packaging and replacement components. That reduces ambiguity when an existing user buys again through a different channel. The commercial risk is unnecessary complexity in a relatively low-value sale. Retail pharmacies and medical suppliers can add value by confirming that the product supplied matches the one named on the order.

Canada

Canada demonstrates why product-level coverage must be examined before describing a country as a single funded mobility market. Ontario's Assistive Devices Program includes forearm crutches for qualifying residents who need a mobility aid for six months or longer. It excludes standard walking canes and most equipment rental. The programme normally covers 75.0% of the approved cost, with the balance paid by the applicant unless additional assistance applies.

The national canes and crutches outlook rises from USD 39.7 million in 2026 to USD 61.3 million in 2036. FMI projects a 4.4% CAGR during 2026 to 2036. These national figures cover more than Ontario and include transactions outside its programme. A 4.4% CAGR leaves Canada 0.1 points below the 4.5% global pace.

For a Canadian distributor, the same customer-facing category can therefore contain different commercial routes. A qualifying forearm-crutch order may need assessment and an approved vendor. A standard cane can remain a direct purchase. FMI expects this distinction to preserve a role for both specialist supply and ordinary retail. Manufacturers should avoid a single price proposition for the whole category. The relevant offer depends on the device and purchasing pathway. A household replacing a familiar cane may value a readily identifiable model, while a funded transaction needs the correct process before purchase. National market entry should account for provincial differences, since Ontario's rules do not extend to all Canadian buyers.

Australia

Australian disability funding distinguishes low-cost assistive technology from more expensive equipment. The NDIS page current to August 2026 defines low-cost items as below AUD 1,500.0 and lists walking sticks or canes among its examples. It still requires an item to relate to the participant's disability and satisfy the scheme's funding rules. A low price therefore simplifies part of the purchase process, and eligibility still depends on the participant's circumstances.

Australian canes and crutches revenue is projected at USD 29.8 million in 2026 and USD 46.0 million in 2036. FMI forecasts a 4.4% CAGR from 2026 to 2036. The country's global revenue share remains close to 3.0%. The outlook supports a mix of routine retail supply and purchases made within an individual support arrangement.

For sellers, clear product information is important because low-cost products may be bought through stores or online. A buyer needs to understand what is included and whether the specification matches the intended requirement. FMI sees a commercial opportunity in making ordinary devices easier to select and reorder. This differs from treating the funding threshold as a target selling price. A support costing far below that threshold still needs an appropriate description and a reliable supply route. Imported and locally distributed ranges compete on that practical transaction. Suppliers should also keep disability funding distinct from temporary rehabilitation or other payment arrangements that may bring a person to the same product.

Germany

Germany's walking-aid classification separates hand and walking sticks, forearm crutches and axillary supports. The GKV product-group document also sets out product and service requirements within the assistive-device system. This gives suppliers a defined route for comparing their offer with a reimbursement category. A generic claim that a device is a mobility aid is less useful than a precise match between its intended use and the relevant product group.

Within that structure, FMI expects Germany's canes and crutches revenue to increase from USD 79.4 million in 2026 to USD 116.9 million in 2036. The forecast CAGR is 3.9% from 2026 to 2036. Germany is the second-largest named country by revenue in this assessment. Its value opportunity also depends on the mix of established products and more specialised configurations. Germany moves from 8.0% of global revenue in 2026 to 7.6% in 2036.

One specialist range offers several aluminium walking-stick grip configurations. This supports a commercial distinction between a broad medical distributor and a company concentrating on walking supports. FMI sees room for specialist suppliers where the difference is concrete and visible in a product comparison. Buyers comparing alternatives need the complete device description. The intended use sets requirements that a material designation does not cover. In a reimbursement setting, a precise description also helps a supplier show which product group applies to each configuration.

Japan

Japan's long-term care framework makes the choice between rental and purchase relevant to some walking supports. A Ministry of Health, Labour and Welfare briefing describes the option for eligible walking aids while explicitly excluding crutches from that particular rental-or-purchase choice. It prevents a supplier from assuming that one funding arrangement applies to every item sold under an English-language cane and crutch heading.

Japanese revenue is forecast to move from USD 69.5 million in 2026 to USD 102.3 million in 2036, giving a 3.9% CAGR across 2026 to 2036. FMI assigns Japan a 7.0% revenue share in 2026. That sizeable base supports a continuing market even with growth below the global rate. The commercial assessment should keep product eligibility, provider service and household purchasing separate. Japan's growth is 0.6 percentage points below the 4.5% global CAGR. Japan's share of the world total stands at 7.0% in 2026 and 6.6% in 2036.

Rental and outright purchase also produce different supplier requirements. A rental provider has an interest in repeated issue and maintenance. A household purchasing a support for continued use evaluates the complete product it will retain. FMI's interpretation is that a manufacturer benefits from explaining which replacement components remain available and how its range is organised. Sales teams need local product-category knowledge before translating a global catalogue into a Japanese offer.

United Kingdom

Equipment reuse is a visible commercial consideration in British institutional supply. Mid Cheshire Hospitals opened a service in February 2026 accepting walking sticks and elbow crutches at Leighton Hospital. Returned items are assessed and then cleaned and refurbished when suitable for reissue. This is evidence from one provider. It shows how an institution can support additional users with fewer replacement purchases.

The UK market is projected at USD 59.6 million in 2026 and USD 87.6 million in 2036. FMI forecasts a 3.9% CAGR over 2026 to 2036. A product may remain in circulation across more than one care episode. Revenue adds USD 28.0 million across the decade, and its global revenue share eases to 5.7% from 6.0%. In the canes and crutches market, the United Kingdom grows 3.9% a year, 0.6 points below the global rate.

For a manufacturer selling into a reuse programme, the design of wear components and the clarity of the product identification can affect commercial appeal. An institution needs to decide whether returned equipment can be safely issued again. A fragmented range with unclear replacement parts creates a different operating burden from a stable assortment. Consumer purchasing remains a separate opportunity, particularly when the user wants an alternative configuration. FMI therefore sees the UK market as a combination of institutional replacement and household choice. The relative weight of those routes differs by customer.

France

France offers a more visible administrative record of reimbursed device spending than a simple retail total. Assurance Maladie includes canes among the products within its LPP medical-device information. Its public series covers reimbursed expenditure and beneficiaries, with 2025 expenditure files listed in September 2026. These are reimbursement records.

FMI estimates French revenue at USD 59.6 million in 2026, increasing to USD 87.6 million in 2036. The country's projected CAGR is 3.9% from 2026 to 2036. A stable national growth rate still leaves room for differences between funded devices, direct retail replacements and products carrying a higher customer payment. The relevant commercial question concerns which purchasing route a supplier is actually serving. Revenue in France climbs by USD 28.0 million, joint sixth among the ten. France's share of global revenue eases from 6.0% to 5.7%.

Invacare's European documentation includes both canes and several crutch families, with a French country selection. This gives distributors access to a defined product-support route. For distributors, maintaining the connection between the product reference and its local documentation matters when a customer replaces an existing model. FMI expects a clear catalogue to remain useful as online purchasing develops. Product descriptions should distinguish a walking cane from a crutch and identify the supplied quantity. Repeatable replacement sales can sit alongside higher-value specialist offers, giving distributors more than one way to develop an established customer relationship.

Italy

Italian institutional access is organised through a national assistive-device framework and local delivery arrangements. The Alessandria health authority describes direct supply or provision through contracted centres under the national nomenclature and regional rules. Its listed equipment includes crutches. This local description is useful evidence of a service route.

FMI forecasts Italian revenue to increase from USD 39.7 million in 2026 to USD 58.4 million in 2036. Growth is projected at 3.9% CAGR over 2026 to 2036. The national market retains a 3.8% global revenue share at the end of the period. For a supplier, that supports a continuing conventional-device business alongside selective demand for more specialised options. The USD 18.7 million rise over the decade ranks Italy ninth for increase. In the canes and crutches market, Italy ranks joint seventh of ten on 2026 revenue. Italy's 3.9% CAGR trails the 4.5% global rate by 0.6 percentage points.

Institutional buyers may require a defined product within a service arrangement, while a household may be replacing a support it already knows. FMI's commercial reading is that local relationships can be as important as an extensive global catalogue. A company selling through contracted centres needs to understand the specific purchasing route. A retailer has to make the product comparison accessible at the point of sale. Both routes benefit from a stable set of references, but their administrative and customer-support requirements differ.

Who are the notable companies in the Canes and Crutches Market?

Notable companies in the Canes and Crutches Market include Medline Industries, Drive DeVilbiss Healthcare, operating under the Drive Medical brand, Invacare, Compass Health Brands and Ossenberg.

Competition combines broad medical supply with narrower product specialisation. Medline's consumer range includes conventional canes and forearm crutches. Drive Medical offers a cane and crutch assortment within a larger durable medical equipment portfolio. Invacare maintains European documentation for several cane and crutch families. Ossenberg concentrates more visibly on walking supports and their configurations.

The company boundary also matters. Drive's January 2026 Compass announcement named Carex and ProBasics among the brands involved. Its German release later described the acquisition and integration. Compass should therefore be evaluated with that relationship in mind, and not treated as a fully independent rival in every comparison.

Ottobock's disclosed core activities concern prosthetics, neuro-orthotics and patient care. Karma's public catalogue is strongly centred on wheelchairs and related mobility products. Both companies participate in the wider rehabilitation chain, where a care provider or mobility supplier may serve different stages of a person's needs. Their activities are distinct from a conventional cane assortment. The wider wheelchairs market is commercially adjacent and remains outside the product values in this report.

Key Developments in the Canes and Crutches Market

• In January 2026, Drive Medical announced a definitive agreement to acquire Compass Health Brands. The later German corporate communication described the acquisition and integration. The development changes the relationship between broad DME supply and Carex and ProBasics consumer medical brands.

Key Players in the Canes and Crutches Market

• Medline Industries
• Drive DeVilbiss Healthcare, operating under the Drive Medical brand
• Invacare
• Compass Health Brands
• Ossenberg
• Ottobock
• Karma Healthcare

Canes and Crutches Market Report Scope

Table 6: Canes and Crutches Market Report Scope

Coverage field	Report scope
Market definition	Walking canes plus forearm and underarm crutches sold for mobility support and rehabilitation
Product coverage	Canes, forearm crutches and underarm crutches
Material coverage	Aluminium, wood, and carbon and composite categories. Plastic components are included within complete devices
Distribution	Retail pharmacies, online, hospitals and clinics, and medical supply stores
Revenue unit	USD million
Volume basis	Million device units. Not unique users or rehabilitation episodes
Named countries	United States, Germany, Japan, United Kingdom, France, China, Italy, Canada, Australia and India
Additional coverage	Rest of world aggregate
Boundaries	Excludes walker and wheelchair sales, rehabilitation services and unrelated mobility equipment
Quantitative Units	USD million

Source: Future Market Insights analysis of the canes and crutches market, 2026.

Canes and Crutches Market Research Methodology

The assessment combines FMI's canes and crutches outlook with secondary review of original government coverage information, health-service notices and manufacturer documentation. Revenue, volume and category relationships were checked for consistent units and forecast periods. Country discussion examines the local purchasing mechanism without presenting programme statistics as total market sales. Competitive analysis separates documented direct products from adjacent rehabilitation activities and distinguishes announced transaction terms from later company descriptions.

Canes and Crutches Market by Segments

Canes and Crutches Market segmented by Product:

• Canes
• Forearm crutches
• Underarm crutches

Canes and Crutches Market segmented by Material:

• Aluminium
• Wood
• Carbon and composite

Canes and Crutches Market segmented by Distribution:

• Retail pharmacies
• Online
• Hospitals and clinics
• Medical supply stores

Canes and Crutches Market by Region

• North America
  • United States
  • Canada
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
• East Asia
  • Japan
  • China
• South Asia and Pacific
  • India
  • Australia
• Rest of world aggregate outside the ten named countries

Research Sources and Bibliography

• Assurance Maladie. (2025, November 24, series listings updated 2026). Dispositifs médicaux inscrits à la liste des produits et prestations (LPP). https://www.assurance-maladie.ameli.fr/etudes-et-donnees/par-theme/medicaments-et-dispositifs-medicaux/dispositifs-medicaux-lpp
• Azienda Sanitaria Locale Alessandria. (Accessed November 9, 2026). Assistenza protesica e integrativa. https://http.aslal.it/assistenza-integrativa-e-protesica-5580
• Centers for Medicare & Medicaid Services. (2020, January 1, current revision accessed November 9, 2026). Canes and Crutches, Local Coverage Determination L33733. https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=33733
• Drive Medical. (2025, December 1). Drive DeVilbiss Healthcare Returns to Drive Medical Brand. https://www.drivemedical.com/blog/drive-medical-rebranding?hs_amp=true
• Drive Medical. (2026, January 29). Drive Medical Acquires Compass Health Brands. https://www.drivemedical.com/news-article/drive-medical-acquires-compass-health-brands
• Drive Medical at Home. (Accessed November 9, 2026). Canes and Crutches for Balance Support. https://drivemedicalathome.com/collections/canes-crutches
• Drive Medical Germany. (Accessed 2026, November 9). Press Release: Drive Medical Acquires Compass Health Brands. https://drivemedical.de/en/news-artikel/2026/press/pm_compass_health
• GKV-Spitzenverband. (2022, December 9, accessed November 9, 2026). Fortschreibung der Produktgruppe 10 Gehhilfen. https://www.gkv-spitzenverband.de/media/dokumente/krankenversicherung_1/hilfsmittel/fortschreibungen_aktuell/12_2022/20221209_Fortschreibung_Produktgruppe_10_Gehhilfen.pdf
• Government of Ontario. (2025, July 10). Mobility aids. Assistive Devices Program eligibility, covered products and purchasing process. https://www.ontario.ca/page/mobility-aids
• Invacare International GmbH. (Accessed November 9, 2026). Canes and crutches. European Resource Center. https://invacaredocs.com/eu-en/3301_EU/
• Karma Healthcare, Karma Medical India. (Accessed November 9, 2026). Corporate product categories and Indian branch network. https://www.karmamedical.com/en-in/
• Medline at Home. (Accessed November 9, 2026). Canes & Crutches. Manufacturer consumer product assortment. https://athome.medline.com/en/categories/mobility/canes-crutches
• Medline Newsroom. (2025, May 9). Medline opens the curtains on second AutoStore addition in Rialto, Calif. https://newsroom.medline.com/supply-chain/medline-second-autostore-rialto/
• Ministry of Health, Labour and Welfare, Japan. (2025, November 13). Overview of welfare equipment and home modifications. Second evaluation meeting, Reference 2. https://www.mhlw.go.jp/content/12300000/001594788.pdf
• National Disability Insurance Agency, Australia. (2026, August 31). What is low-cost assistive technology. https://www.ndis.gov.au/participants/assistive-technology/types-assistive-technology/what-low-cost-assistive-technology
• NHS Cheshire and Merseyside. (2026, February 4). Hospital launches walking aid reuse service to support patient care and cut waste. https://www.cheshireandmerseyside.nhs.uk/your-locality/cheshire-east/cheshire-east-news/hospital-launches-walking-aid-reuse-service-to-support-patient-care-and-cut-waste
• Ossenberg GmbH. (2024). Katalog Ossenberg 2024. Carbon forearm-crutch configurations and product assortment. https://bilder.ossenberg.com/e-Paper/epaper-Katalog_Ossenberg_2024/index.html
• Ossenberg GmbH. (Accessed November 9, 2026). Leichtmetallstöcke. Manufacturer aluminium walking-stick assortment. https://shop.ossenberg.com/Produkt-Kategorie/gehst%C3%B6cke/leichtmetallstoecke/
• Ottobock. (2026, March 19). Ottobock publishes Annual Report 2025. https://corporate.ottobock.com/en/media/newsroom/ottobock-publishes-annual-report-for-2025
• Press Information Bureau, Government of India. (2025, October 28). Older persons in India: population, challenges and government initiatives. Hindi briefing. https://static.pib.gov.in/WriteReadData/specificdocs/documents/2025/oct/doc20251028678701.pdf
• State Administration for Market Regulation, China. (2025, May 26). Silver market drives rapid growth of age-friendly products: 28,700 new varieties in January to April. Original Chinese notice. https://www.samr.gov.cn/xw/zj/art/2025/art_abc34293ddcc48d581ccd00b413df0ce.html
• World Health Organization. (2024, January 2). Assistive technology. https://www.who.int/news-room/fact-sheets/detail/assistive-technology

This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations.